The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Insulin — What You Need to Know
If you take insulin for type 2 diabetes and are considering Mounjaro (tirzepatide) for weight management, you may be wondering how they work together. Mounjaro is not insulin — it's a dual GIP and GLP-1 receptor agonist that works differently to support blood sugar control and weight loss. However, combining Mounjaro with insulin requires careful medical oversight because both affect blood sugar levels. This guide explains how they interact, eligibility considerations, and how to access Mounjaro safely whilst taking insulin in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro Works Alongside Insulin
Mounjaro and insulin work through different mechanisms. Insulin is a hormone that directly lowers blood sugar by helping glucose enter cells. Mounjaro (tirzepatide) activates two hormone pathways — GIP and GLP-1 — which regulate appetite, slow stomach emptying, and support insulin release in response to food. When used together, they can complement each other, but this also means there's a risk of blood sugar dropping too low (hypoglycaemia).
If you're taking insulin and start Mounjaro, your prescriber may need to adjust your insulin dose as Mounjaro helps your body regulate blood sugar more effectively. This is why it's essential that both your GP and specialist weight management service communicate about your treatment. Your insulin dose might be reduced gradually as Mounjaro starts working, or your blood sugar targets may need recalibrating.
- Mounjaro is not a replacement for insulin
- Both medications lower blood sugar — dose adjustments may be needed
- Regular blood sugar monitoring (HbA1c, fasting glucose) is important
- Your GP and specialist must coordinate your care
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Accessing Mounjaro If You Take Insulin
In the UK, Mounjaro is accessed through NHS specialist tier 3/4 weight management services or private prescription following an online clinical assessment. Eligibility for prescription weight loss treatment is typically BMI ≥30, or BMI ≥27 with weight-related health conditions — type 2 diabetes qualifies. If you take insulin, your prescriber will review your diabetes management, current medications, and blood sugar control before approving Mounjaro.
Private online consultations with UK-licensed prescribers can assess your suitability quickly without NHS waiting lists, though costs vary by dose. Whichever route you choose, inform your prescriber immediately about insulin use so they can coordinate with your GP and ensure safe dose titration. Your GLP-1 weight loss calculator above can help estimate potential outcomes, whilst your progress tracker is useful for logging blood sugar readings alongside weight changes during treatment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I take Mounjaro and insulin together?
Yes, you can take both, but they both lower blood sugar so your insulin dose may need reducing. Your prescriber and GP must coordinate your care, and you'll need regular blood sugar monitoring (HbA1c, fasting glucose). Never adjust insulin yourself — always follow your healthcare team's guidance.
Does Mounjaro replace insulin?
No. Mounjaro is not insulin and does not replace it. Mounjaro supports blood sugar regulation through a different mechanism (GIP and GLP-1 receptor activation), but insulin is still needed for type 2 diabetes. Mounjaro may allow your insulin dose to be reduced if blood sugar improves, but only your prescriber can decide this.
Will I need more frequent blood sugar monitoring on Mounjaro and insulin?
Yes, likely. When starting Mounjaro whilst taking insulin, more frequent monitoring helps identify if your insulin dose needs adjusting. Your GP may request HbA1c tests every 4–12 weeks initially, and you may be asked to log home blood sugar readings more regularly to track patterns.
How do I access Mounjaro in the UK if I take insulin?
Through NHS tier 3 specialist weight management services (referral from GP, typically with waiting lists) or private prescription via online consultation with a UK-licensed prescriber. Either way, inform your prescriber about insulin use upfront so they can assess safety and coordinate with your GP on dose adjustments.
What's the difference between Mounjaro and Wegovy if I take insulin?
Both are once-weekly injections for weight management. Mounjaro is a dual GIP and GLP-1 agonist; Wegovy (semaglutide) is GLP-1 only. Both can be used with insulin, but both affect blood sugar — your insulin dose may need adjusting. Your prescriber will recommend the most suitable option for your diabetes control.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.